Vincenza Conteduca

39PUBLICATIONS
131CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Aug 22, 2026
Patterns of first-line treatment selection in metastatic renal cell carcinoma: a real-world analysis from the Meet-URO 33-REGAL study.

|Aug 18, 2026
Global Real-World Outcomes of Olaparib in Metastatic Castration-Resistant Prostate Cancer Patients With Homologous Recombination Repair Alterations.

|Aug 13, 2026
BRCA Testing in Prostate Cancer: A Histopathologist's Perspective.

|May 28, 2026
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.

|Mar 09, 2026
Exploring DNA Damage Repair Therapeutics in Prostate Cancer beyond BRCAness.

Fabrizio Di Costanzo, Jack Williamson, Craig N Robson

|Dec 24, 2025
The Role of Homologous Recombination Deficiency (HRD) in Renal Cell Carcinoma (RCC): Biology, Biomarkers, and Therapeutic Opportunities.

Alberto Bongiovanni, Pierfranco Conte, Vincenza Conteduca

Pageof 7

Frequent Collaborators

12 joint publications

Ugo De Giorgi

7 joint publications

Giuseppe Schepisi

7 joint publications

Michael Sigouros

6 joint publications

Chiara Casadei